Overview
Support Groups
Latest News
Events
Clinical Trials
Alagille syndrome
-
Jan 31, 2019 www.modernreaders.com
Analysts Set Albireo Pharma Inc (ALBO) PT at $56.33 – Modern Readers
Read More -
Jan 30, 2019 www.fairfieldcurrent.com
Albireo Pharma Inc (ALBO) Shares Sold by Renaissance Technologies LLC – Fairfield Current
Read More -
Jan 25, 2019 www.fairfieldcurrent.com
BlackRock Inc. Buys 59,901 Shares of Albireo Pharma Inc (ALBO) – Fairfield Current
Read More -
Jan 25, 2019 pharmaphorum.com
Market access roundup: The US fights back against price hikes – pharmaphorum
Read More -
Jan 24, 2019 www.fairfieldcurrent.com
Brokerages Set Albireo Pharma Inc (ALBO) PT at $56.33 – Fairfield Current
Read More -
Jan 23, 2019 www.fairfieldcurrent.com
Albireo Pharma (ALBO) Downgraded by BidaskClub to “Strong Sell” – Fairfield Current
Read More -
Jan 23, 2019 www.digitaljournal.com
Global Arrhythmogenic Right Ventricular Dysplasia Treatment Market Trends, Opportunities & Growth Forecast During 2018-2026 – Press Release – Digital Journal
Read More -
Jan 22, 2019 www.ptcommunity.com
Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliary Atresia – P&T Community
Read More -
Jan 22, 2019 www.tapinto.net
Verona Police Welcome Very Young Officer into Their Ranks – TAPinto.net
Read More
